| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.23 | 0.003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |